Novel therapies, for instance GLP-1 receptor agonists and SGLT2 inhibitors, are safer because they are doing not lead to hypoglycemia, are weight neutral or lead to weight loss and blood pressure and impact vascular complications favorably.Far too much glucose from your liver. When your blood sugar is low, your liver tends to make and sends out gl

Article Under Review